These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2173051)

  • 1. [Medullary carcinoma of the thyroid and 99mTc(V)-DMSA scintigraphy. Clinical results with a new radiopharmaceutical].
    Kujat C; Neidl K; Müller-Leisse C
    Rofo; 1990 Nov; 153(5):495-500. PubMed ID: 2173051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tc-99m-(V)-DMSA: the new sensitive and specific radiopharmaceutical for imaging metastases of medullary thyroid carcinomas?
    Becker W; Börner W; Reiners C
    Horm Metab Res Suppl; 1989; 21():38-42. PubMed ID: 2553574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m-pentavalent dimercaptosuccinic acid uptake in Hurthle cell tumor of the thyroid.
    Vergara E; Lastoria S; Varrella P; Lapenta L; Salvatore M
    J Nucl Biol Med (1991); 1993 Jun; 37(2):65-8. PubMed ID: 8396979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More on [99mTc](V)DMSA scintigraphy in patients with medullary carcinoma of the thyroid.
    Mojiminiyi OA; Udelsman R; Shepstone BJ; Dudley NE; Soper ND
    J Nucl Med; 1989 Aug; 30(8):1420. PubMed ID: 2547036
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma.
    Verga U; Muratori F; Di Sacco G; Banfi F; Libroia A
    Henry Ford Hosp Med J; 1989; 37(3-4):175-7. PubMed ID: 2576958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of 99mTc(V)-dimercapto succinic acid (DMSA) for imaging medullary carcinoma of thyroid and its metastasis.
    Patel MC; Patel RB; Ramanathan P; Ramamoorthy N; Krishna BA; Sharma SM
    Eur J Nucl Med; 1988; 13(10):507-10. PubMed ID: 2836203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
    Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
    J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tc-99m DMSA scintigraphy on patients with medullary thyroid carcinoma.
    Groth P; Unterspann S; Schwähn D; Stoll I; Reincke R
    Radiobiol Radiother (Berl); 1987; 28(5):642-4. PubMed ID: 2831560
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation and clinical evaluation of technetium-99m dimercaptosuccinic acid for tumour scintigraphy.
    Hirano T; Tomiyoshi K; Zhang YJ; Ishida T; Inoue T; Endo K
    Eur J Nucl Med; 1994 Jan; 21(1):82-5. PubMed ID: 8088289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.
    Ugur O; Kostakğlu L; Güler N; Caner B; Uysal U; Elahi N; Haliloğlu M; Yüksel D; Aras T; Bayhan H; Bekdik C
    Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience in imaging medullary thyroid carcinoma using 99mTc (V) dimercaptosuccinic acid (DMSA).
    Clarke S; Lazarus C; Maisey M
    Henry Ford Hosp Med J; 1989; 37(3-4):167-8. PubMed ID: 2576956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid.
    Hilditch TE; Murray T; Connell JM; McLellan AR; Reed NS
    J Nucl Med; 1988 Oct; 29(10):1746-7. PubMed ID: 2845025
    [No Abstract]   [Full Text] [Related]  

  • 13. Technetium-99m(V)-DMSA in the imaging of medullary thyroid carcinoma.
    J Nucl Med; 1987 Feb; 28(2):252-3. PubMed ID: 3027281
    [No Abstract]   [Full Text] [Related]  

  • 14. Positive scintigraphy of medullary thyroid cancer using 201Tl and alkalized 99mTc-DMSA.
    Holub V; Nĕmec J; Neradilová M; Benová M; Blazek T; Dusek M
    Radiobiol Radiother (Berl); 1987; 28(5):640-2. PubMed ID: 2831559
    [No Abstract]   [Full Text] [Related]  

  • 15. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
    Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
    J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentavalent Tc-99m DMSA scintigraphy. Prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid.
    Mojiminiyi OA; Udelsman R; Soper ND; Shepstone BJ; Dudley NE
    Clin Nucl Med; 1991 Apr; 16(4):259-62. PubMed ID: 1646098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new imaging agent for medullary carcinoma of the thyroid.
    Ohta H; Yamamoto K; Endo K; Mori T; Hamanaka D; Shimazu A; Ikekubo K; Makimoto K; Iida Y; Konishi J
    J Nucl Med; 1984 Mar; 25(3):323-5. PubMed ID: 6321700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid.
    Clarke SE; Lazarus C; Mistry R; Maisey MN
    Br J Radiol; 1987 Nov; 60(719):1089-92. PubMed ID: 2825895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of 99mTc(V)-DMSA complex: studies in medullary carcinoma of thyroid.
    Ramamoorthy N; Shetye SV; Pandey PM; Mani RS; Patel MC; Patel RB; Ramanathan P; Krishna BA; Sharma SM
    Eur J Nucl Med; 1987; 12(12):623-8. PubMed ID: 3034614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. False-positive Tc-99m pentavalent DMSA uptake in the imaging of medullary carcinoma of the thyroid.
    Lette J; Monier D; Ledoux R; Levasseur A
    Clin Nucl Med; 1991 Feb; 16(2):136-7. PubMed ID: 1848495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.